The centralised negotiation on some drugs needed during the Covid-19 crisis reignited the debate around whether each Member State should continue to act independently on such matters
Interview with Claudio Jommi
giadaApril 2021
Progress and sustainable development are not just lucky events though
Claudia Bolaffi
giadaDecember 2020
Today is a time of hesitant exit from a nightmare and uncertainty about the forms of the future to give concrete form to innovative health policy projects
Rodolfo Saracci
giadaJune 2020
The epidemic made us recalcitrant toward complexity but in medicine uncertainty is a value
Interview with Paolo Giordano
giadaJune 2020
The loneliness of health workers, victims of the sluggishness of others and the resulting lack of risk management
Claudio Beltramello
giadaJune 2020
AIFA adopts the Grade method to evaluate the innovativeness of drugs.
Interview with Holger Schünemann
giadaSeptember 2017
©